Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Velsera

News headline image
Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth
From Velsera
Via Business Wire
News headline image
Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey
From Velsera
Via Business Wire
News headline image
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera's Release of CGW Plus
From Velsera
Via Business Wire
News headline image
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
From Velsera
Via Business Wire
News headline image
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
From Velsera
Via Business Wire
News headline image
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
From Velsera
Via Business Wire
News headline image
Velsera Launches Faster, Smarter Clinical Interpretation Workflows for Analyzing and Reporting on Genetic Sequence Data
From Velsera
Via Business Wire
News headline image
Velsera and Solaris Health Partner to Expand Access to Genetic Testing that Helps Urology Patients Understand Cancer Risks
From Velsera
Via Business Wire
News headline image
Velsera Makes NVIDIA Parabricks Tools Available for Global Researchers on the Seven Bridges Platform
From Velsera
Via Business Wire
News headline image
Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe
From Velsera
Via Business Wire
News headline image
Velsera Announces Appointment of Two New Board Members
From Velsera
Via Business Wire
News headline image
Velsera to Showcase Significantly Expanded Bioinformatics Capabilities at 2023 Bio-IT World Conference
From Velsera
Via Business Wire
News headline image
Velsera’s 2023 Diagnostics & Discovery Summit: Shaping the Future of Precision Medicine
From Velsera
Via Business Wire
News headline image
New Company, Velsera, Represents Summa Equity's Vision to Improve Global Health Outcomes
From Velsera
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.